Resources & Insights

Make the
evidence visible.

Stories, research and organisational learning gathered in one place.

Featured resource / Latest News

When the work stopped, TB did not.

When USAID funding for ACCELERATE 1 ended abruptly, years of work bringing TB screening, diagnosis, treatment and prevention closer to vulnerable communities in South Africa’s Eastern Cape came to a sudden halt. Dr Priashni Subrayen reflects on what was lost, what happened to patients and staff, and how an unexpected lifeline allowed a smaller team […]

Read the story

Latest News

When Leadership Matters Most

Dr Phindi Nxumalo Senior Technical Director How Dr P led through one of Aurum’s most challenging periods “We had to think about our staff, our patients and what needed to happen next.” On a Monday morning in January, Dr Phindi Nxumalo, known to colleagues affectionately as Dr P, received a call she will never forget. […]

Read the story

Latest News

Africa Voices of Science – Prof Vinodh Edward

Aurum Group Chief Operating Officer Prof Vinodh Edward has been named one of Speak Up Africa’s 2025 African Voices of Science (AVoS) Champions, joining a continental cohort of leaders working to strengthen African voices in health research, policy and innovation. Selected from a competitive cohort of health research and development leaders across Kenya, Côte d’Ivoire, […]

Read the story

Latest News

Pearl Khwezi visits Aurum’s clinical research site

International Broadway actress Pearl Khwezi recently visited Aurum’s Tembisa Clinical Research Site to learn more about the organisation’s clinical research work. During the visit, Pearl engaged with Aurum’s research teams and explored the work of the Clinical Research Division, including clinical trials and vaccine research. The visit provided an opportunity to see how research is […]

Read the story

Latest News

Dr Tonderai awarded NIHR Global Advanced Fellowship

Aurum’s Dr Tonderai Mabuto, Specialist Scientist has been awarded an NIHR Global Advanced Fellowship, recognising his work to strengthen HIV research and health systems across sub-Saharan Africa. The fellowship will support his research into improving care after hospital discharge within HIV programmes, with a focus on developing practical solutions informed by the experiences of patients, […]

Read the story

Latest News

AIDS 2026: Evidence, Partnership and Community in Action

From advanced HIV disease to community-led research, Aurum and IMPAACT4HIV brought evidence, expertise and lived experience to AIDS 2026 in Rio de Janeiro. The IMPAACT4HIV Satellite Session was a key moment of the week, bringing partners, policymakers, researchers and community leaders together to ask an important question: How do we build advanced HIV disease care […]

Read the story

Latest News

When youth thrive, the HIV epidemic shifts

Across South Africa’s North West province, Aurum’s Youth Care Clubs (YCCs) are creating safe, youth-led spaces that restore confidence, build resilience, and ensure that young people living with HIV can access the care they need without fear, stigma, or judgement. Inside clinic rooms and community halls, adolescents gather each month to do far more than […]

Read the story

Latest News

Prof Geoffrey Setswe on the Impact of HIV Funding Cuts in South Africa

As the global HIV community gathered for AIDS 2026, questions around the sustainability of the HIV response are more urgent than ever. SABC News Specialist Health Reporter Zandile Myeza spoke to Prof Geoffrey Setswe, CEO of Aurum South Africa, about the impact of the withdrawal of PEPFAR funding on HIV programmes in South Africa and […]

Read the story

Latest News

Aurum at SA TB 2026: Bringing Evidence to the TB Response

TB remains one of South Africa’s most urgent health challenges. At the 9th SA TB Conference, Aurum researchers and experts joined partners from across the TB community to share evidence, challenge current approaches and explore what it will take to end TB. Under the conference theme Vuka: Let’s unite towards a TB-free world, Aurum contributed […]

Read the story

Latest News

World TB Month 2026: Putting Faces to the TB Response

We marked World TB Month under the theme “Led by Communities. Powered by Innovation.” Across our programmes, we used the month to put people, research and real-world impact at the centre of the TB conversation. TB Diagnostics Have a Face Our TB Diagnostics Have a Face campaign brought the human side of TB diagnosis into […]

Read the story

Latest News

Bringing Rapid TB Diagnosis Closer to Communities

A new generation of rapid TB diagnostics is set to reach 13 countries, bringing accurate testing closer to communities that have previously lacked access. Supported by the Children’s Investment Fund Foundation (CIFF) funded by The Global Fund and implemented on the ground by Aurum Institute, the initiative will deliver nearly three million fast, accurate TB […]

Read the story

Latest News

Aurum Laboratory earns SANAS accreditation.

The Aurum Institute’s Biomedical Research Laboratory (BRL) in Tembisa has become the first laboratory within Aurum to receive accreditation from the South African National Accreditation System (SANAS) under the ISO 15189:2022 standard — the internationally recognised benchmark for quality and competence in medical laboratories. In practical terms, this means the laboratory has been independently assessed […]

Read the story

Latest News

SUPREME-SECURE launches call to improve maternal health.

SUPREME-SECURE is inviting manufacturers of blood pressure measuring devices to help expand access to home-based blood pressure monitoring for pregnant women through a new Request for Proposals (RFP) focused on validation, regulatory approval and market access in sub-Saharan Africa. Hypertensive disorders of pregnancy, particularly pre-eclampsia, remain among the leading direct causes of maternal death worldwide, […]

Read the story

Latest News

Prof Geoffrey Setswe to lead Aurum South Africa as CEO.

The Aurum Institute, a leading Africa-based global health organisation, today announced the appointment of Professor Geoffrey Setswe as Chief Executive Officer of Aurum Institute South Africa, effective 1 July 2026. Aurum Institute South Africa is the largest country entity within The Aurum Institute Group and plays a central role in the organisation’s research, health systems […]

Read the story

Latest News

Dr Jirair Ratevosian joins Aurum USA board.

The Aurum Institute USA is pleased to announce the appointment of Dr. Jirair Ratevosian, BA, BS, DrPH, to its Board of Directors effective July 1, 2026. Dr Ratevosian joins the Board at a pivotal time for global health and international development, bringing more than two decades of leadership experience across government, academia, philanthropy, multilateral institutions, […]

Read the story
2026 67 publications

Guiding principles for pragmatic randomised trials of tuberculosis treatments

Phillips PPJ, Schumacher SG, Cassino C, Charalambous S, Chaisson RE, Churchyard GJ, et al.

Lancet Infect Dis. 2026 Aug 14:S1473-3099(26)00359-2.

View publication

From Risk to Care: Rethinking Emergency Contraception Access for Youth

Wand H, Govender V

Arch Sex Behav. 2026 Aug 10.

View publication

Tuberculosis treatment support using digital adherence technology

Maraba N, Dube T, Charalambous S

BMJ. 2026 Aug 6;394:e100492.

View publication

The effect of metformin on the pharmacokinetics of rifampicin, isoniazid, and pyrazinamide in adults with tuberculosis

Rossouw J, Wallis R, Kornfeld H, Singhal A, Maartens G, Wiesner L, et al.

Antimicrob Agents Chemother. 2026 Aug 6:e0074826.

View publication

Inflammatory biomarkers of asymptomatic and symptomatic tuberculosis

Awany D, Ariefdien DT, Mendelsohn SC, Rozot V, Mulenga H, Nyangu S, et al.

Nat Commun. 2026 Jul 25;17(1):9079.

View publication

New tuberculosis vaccines for people with HIV

Sumner T, Clark RA, Prys-Jones TO, Bakker R, Churchyard G, White RG

AIDS. 2026 Jul 23.

View publication

Towards culture-free sequencing of Mycobacterium tuberculosis: evaluating new targeted and whole-genome approaches for genotyping and drug resistance profiling

Iannucci I, Di Marco F, Moghaddasi K, Miotto P; *POR TB study group; Cabibbe AM, Cirillo DM

Genome Med. 2026 Jul 21.

View publication

The Provision of Care for Patients with Tuberculosis and Diabetes Mellitus Multi-Morbidity in Addis Ababa, Ethiopia: An Analysis of Patients' Perspectives

Salato ST, Setswe KG

Int J Environ Res Public Health. 2026 Jul 18;23(7):925.

View publication

'Why should I start medication when I am not feeling sick?' A qualitative study of refusal, initiation, completion and discontinuation of tuberculosis preventive treatment among people living with HIV in sub-Saharan Africa

Tsope L, Chimoyi L, Kennar A, Rabothata I, Sisay S, Sithole K, et al.

BMJ Public Health. 2026 Jul 14;4(3):e004163.

View publication

Quantifying emergent drug-resistant TB using laboratory data and record-linkage methods

Rhea CH, Maruri F, Ghebrekristos Y, Amorim G, Cox H, Dheda K, et al.

IJTLD Open. 2026 Jul 13;3(7):428-434.

View publication

Hidden in Success: Gendered Patterns of Suboptimal Care Engagement Among Tuberculosis Patients Who "Successfully" Completed Treatment in South Africa

Medina-Marino A, Arua E, de Vos L, Fiphaza K, Bezuidenhout D, Ngcelwane N, et al.

Clin Infect Dis. 2026 Jul 8;82(6):e1292-e1301.

View publication

Reported Effectiveness of a Text-Based Post-Operative Care Intervention After Voluntary Medical Male Circumcision (VMMC) to Improve Quality of Care and Adverse Events Identification in Sub-Saharan Africa: A Scoping Review

Makhele C, Duah E, Morerwa S, Maluleke K

Health Sci Rep. 2026 Jul 4;9(7):e72752.

View publication

Cost-effectiveness analysis of implementing a medication monitor and differentiated care approach among people with TB in South Africa

Mukora R, Pelusa R, Maraba N, Orrell C, Jennings L, Naidoo P, et al.

BMC Public Health. 2026 Jul 2.

View publication

Differentiated HIV Service Delivery vs Conventional Care: Tuberculosis Preventive Therapy Outcomes for People Living With HIV in Sub-Saharan Africa

Johnson AE, Chimoyi L, Charalambous S, Kawaza N, Hoffmann CJ, Davis JL, Chihota V

J Acquir Immune Defic Syndr. 2026 Jul 1;101(7):760-767.

View publication

Potentials and challenges of next generation sequencing-guided individualized treatment for management of rifampicin-resistant tuberculosis - A qualitative study

Trang TPH, Barrenechea-Pulache A, De Wet K, Fanampe B, Charalambous S, Van Rie A

PLoS One. 2026 Jun 26;21(6):e0350514.

View publication

Sexual Behaviors and Psychosocial Health Among Men Who Have Sex with Men with and without Female Partners in Kenya: Baseline Findings from the Tatu Pamoja Study

Vu K, Mehta SD, Wahome E, van der Elst E, Mohamed K, Aloo T, et al.

J Sex Res. 2026 Jun 26:1-12.

View publication

Advancing national preparedness for the introduction of novel tuberculosis vaccines in South Africa: policy, evidence, and system readiness insights from a national workshop

Ndjeka N, Subrayen P, Hanekom WA, Jassat W, Luabeya AKK, Mkhondo N, et al.

Vaccine. 2026 Jun 20;86:128755.

View publication

Lung function impairment at pulmonary TB and HIV/TB diagnosis: a South African cross-sectional cohort analysis

Marll M, Ngwanto T, Mofokeng N, Mngomezulu L, El Sammak S, Rajaratnam A, et al.

BMJ Open Respir Res. 2026 Jun 18;13(1):e004248.

View publication

Preserved Spermatogenesis and Hormonal Function in Men Receiving a Pretomanid Regimen (BPaMZ) for Pulmonary Drug-Resistant Tuberculosis

Howell P, Lombardi A, Brumskine W, Mikiashvili L, Boekelheide K, Moreira J, et al.

Clin Pharmacol Ther. 2026 Jun 18.

View publication

The role of interferon-gamma release assays in tuberculosis vaccine trials: strengths, limitations, and implications beyond trial design

Dagnew AF, Schmidt AC, Cinar A, Garcia-Basteiro AL, Noble R, Pelzer PT, et al.

Vaccine. 2026 Jun 10;88:128822.

View publication

Deep learning approach for probabilistic pulmonary function estimation from chest X-ray and peak expiratory flow rate

Killing C, Wekerle M, Sutherland JS, Rassool M, Zurba L, Ivanova O, et al.

Commun Med (Lond). 2026 Jun 9;6(1):330.

View publication

Inclusion of young adolescents in policy development for new tuberculosis vaccines

Hatherill M, Clark RA, Martinez L, Fiore-Gartland AL, Garcia-Basteiro AL, Churchyard GJ, et al.

Lancet Glob Health. 2026 Jun 8:S2214-109X(26)00017-3.

View publication

Interventions to reduce the impact of post-tuberculosis lung disease: a scoping review of the literature

Byrne AL, Günther G, Tadyanemhandu C, de Almeida CPB, Dewi IM, Mitnick CD, et al.

BMC Pulm Med. 2026 Jun 4;26(1):345.

View publication

A proteome-wide atlas of humoral immunity to Mycobacterium tuberculosis across the spectrum of disease

Khan MZ, Irvine EB, Cizmeci D, Davies LRL, Randall AZ, Pablo J, et al.

Front Immunol. 2026 Jun 3;17:1810894.

View publication

Efficacy and safety of a 4-month quabodepistat, delamanid, and bedaquiline regimen for drug-susceptible pulmonary tuberculosis: a multicentre, open-label, randomised, proof-of-concept, non-inferiority, phase 2b/c trial

Dawson R, Diacon AH, Variava E, Moloantoa T, Brumskine W, Ngwanto T, et al.

Lancet Infect Dis. 2026 May 29:S1473-3099(26)00143-X.

View publication

Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial

Chihota V, Waggie Z, Cardenas V, Mngadi K, Ndebele F, Brumskine W, et al.

Clin Infect Dis. 2026 May 17:ciag315.

View publication

Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01E-4 tuberculosis vaccine

Dagnew AF, Noble R, Cinar A, Burhan E, Churchyard G, Fairlie L, et al.

Vaccine. 2026 May 12;85:128690.

View publication

Real-time electronic drug monitoring: experiences from a multinational phase 3 clinical trial to prevent multidrug-resistant TB

Jimah T, Haberer JE, Amico KR, Tinkamanyire J, Kendall MA, Moonsamy S, et al.

IJTLD Open. 2026 May 11;3(5):305-311.

View publication

Restoring certainty to global health regulation

Yang YT, Perehudoff K, Tran B, Churchyard G

BMJ. 2026 May 6;393:s814.

View publication

Performance of Human and Computer-aided Evaluation of Digital Chest Radiography for Community-based Screening of Asymptomatic Tuberculosis

Nyangu S, Mulenga H, Mendelsohn SC, Perumal T, Tameris M, Moloantoa T, et al.

medRxiv [Preprint]. 2026 Apr 30:.

View publication

Investigation of correlates of protection against gonococcal infection by comparative immunoprofiling of responses in experimental and clinical studies

McKeand SA, Bencomo FR, Soc A, Jones RA, Thistlethwaite A, Gu Z, et al.

J Infect Dis. 2026 Apr 29:jiag216.

View publication

Threshold cost of delivering preventive treatment for household contacts of people with multidrug-resistant TB

Young N, Lee JH, Gupta A, Churchyard G, Hesseling AC, Swindells S, et al.

Int J Tuberc Lung Dis. 2026 Apr 27;30(5):225-227.

View publication

Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial

Van Rie A, Conceição EC, Ndebele F, Wells F, Paulse A, Mekonnen EG, et al.

Lancet Respir Med. 2026 Apr 20: S2213-2600(26)00095-0.

View publication

Viral variant but not host factors associate with SARS-CoV-2 viral kinetics

Hahn WO, Fisher LH, Ward A, Grant S, ……, Manentsa M, et al.

Commun Med (Lond). 2026 Apr 17.

View publication

Poor adherence to second-line antiretroviral therapy and its contributing factors among people living with HIV in Addis Ababa, Ethiopia

Feyissa BB, Sisay A, Yalew A, Setswe G

AIDS Res Ther. 2026 Apr 12.

View publication

Dynamics of Quantiferon-Gold Plus results in a large TB preventive treatment trial across three high-burden HIV/TB countries

Saavedra-Cervera B, Nguenha D, Chihota V, Yimer G, Fernández-Escobar C, Mngadi K, et al.

J Infect Dis. 2026 Mar 17:jiag165.

View publication

Editorial: Community-centric strategies for HIV and STI prevention in key populations

Mngadi K, Broder GB

Front Reprod Health. 2026 Mar 16;8:1798107.

View publication

Puthanakit T, Grinsztejn B, Sanders EJ, et al

Landovitz RJ, Pinedo Y, Hinestrosa F, Crofoot ……………

Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study. Clin Infect Dis. 2026 Mar 14:ciag171.

View publication

Overcoming structural barriers to tuberculosis treatment in Africa through digital technologies

Manyazewal T, Kempker RR, Temesgen Z, Orrell C, Ngadaya E, Musiimenta A, et al.

Lancet Microbe. 2026 Mar 13:101399.

View publication

AS01B-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a post-hoc cross-protocol comparison of results from HVTN 100, 107, 120, and 702

Menezes F, Chen S, Grunenberg N, Malahleha M, Mngadi K, Muyoyeta M, et al.

Front Immunol. 2026 Mar 12;17:1768201.

View publication

Feasibility and acceptability of COVID-19 self-testing offered through community screening posts in Mozambique: a mixed-methods study

Issufo S, Mavume-Mangunyane E, Valverde E, Ndima S, Chimoyi L, Penicela C, et al.

BMC Public Health. 2026 Mar 6.

View publication

panTB-HM: a multi-arm clinical trial of a pan-TB regimen targeting both host and microbe

Mudzengi D, Mashatole S, Xiang Q, Adrion C, Glover N, Ngwanto T, et al.

Trials. 2026 Feb 27.

View publication

Targeted and whole-genome sequencing for drug resistance and genetic relatedness inference of rifampicin-resistant Mycobacterium tuberculosis: an in-depth comparison

de Diego Fuertes M, Costa Conceição E, Wells F, Rennie V, Heupink T, Churchyard G, et al.

ERJ Open Res. 2026 Feb 23;12(1):00630-2025.

View publication

Imprecision in tuberculosis infection outcomes: implications for non-inferiority vaccine trials

Grint DJ, White RG, Churchyard G, Fiore-Gartland A, Rangaka M, Garcia-Basteiro AL, Cobelens F

Int J Epidemiol. 2026 Feb 18;55(2):dyag034.

View publication

Risk factors for immunological sensitization to Mycobacterium tuberculosis and progression to incident TB disease among HIV-uninfected adults in a high burden setting

Mulenga H, Mendelsohn SC, Fiore-Gartland A, Penn-Nicholson A, Musvosvi M, Tameris M, et al.

J Infect Dis. 2026 Feb 18:jiag100.

View publication

Tongue swab Mycobacterium tuberculosis qPCR for community screening of asymptomatic TB vs

Wood RC, Olson AM, Lochner KA, Dragovich RB, Ball A, Steadman A, et al.

clinic-based triage of symptomatic TB. medRxiv [Preprint]. 2026 Feb 14:2026.02.12.26346160.

View publication

Host response biomarkers of tuberculosis recurrence and treatment failure

Bauer B, Ahmed MIM, Baranov O, Bakuli A, Lin L, Kisinda A, et al.

Commun Med (Lond). 2026 Feb 14.

View publication

Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling study

Tanvir H, Clark RA, Sumner T, Horton KC, Prŷs-Jones TO, Bakker R, et al.

PLoS Med. 2026 Feb 12;23(2):e1004595.

View publication

Variation in antiviral immunity and inflammation pathways precedes HIV-1 infection in a high-risk African cohort

Kioko M, Mwangi S, Fwambah L, Hassan AS, Blackard JT, Bejon P, et al.

J Clin Invest. 2026 Feb 12:e195172.

View publication

Mycobacterium avium complex (MAC) elimination slopes from sputum are potential treatment response biomarkers in patients with HIV and pulmonary MAC

Pasipanodya JG, Nqwata L, Schmitz J, Srivastava S, Wanjalla CN, Wallis RS, Dooley KE

IJTLD Open. 2026 Feb 11;3(2):97-104.

View publication

Optimized Mass Spectrometry to Uncover M

Nieto Ramirez LM, Shelton K, Belisle JT, Diaz G, Tameris M, Naidoo K, et al.

tuberculosis Biomarkers in Extracellular Vesicles from Asymptomatic Tuberculosis Patients. J Infect Dis. 2026 Feb 10:jiag086.

View publication

A critical juncture: Reimagining a unified, integrated HIV response in South Africa

Rees K, Wolvaardt G, Chidarikire T, Dietrich JJ, Ibisomi L, Kufa-Chakezha T, et al.

S Afr Med J. 2026 Feb 9;116(1):e4454.

View publication

Treatment Outcomes and Drug-Related Adverse Events Across Four Short-Course RR-TB Regimens in South Africa: A Retrospective Analysis

Ndjeka N, Perumal R, Romanowski K, Mathema H, Amusa LB, Campbell JR, et al.

Int J Infect Dis. 2026 Feb 8:108473.

View publication

Virological failure and risk factors among people living with HIV taking second-line ART in Addis Ababa, Ethiopia

Feyissa BB, Sisay A, Davids EL, Yalew A, Setswe G

PLoS One. 2026 Feb 2;21(2):e0330581.

View publication

A qualitative study assessing the acceptability of a multi-agent AI Chatbot for providing HIV and mental health support among men who have sex with men and transgender women in KwaZulu-Natal, South Africa

Humphries H, Msimango L, Tshawe Z, Gcelu N, Ferreira K, Pienaar J, et al.

Trans R Soc Trop Med Hyg. 2026 Feb 2;120(2):160-174.

View publication

Insights on the implementation strategies for a potential new tuberculosis vaccine in South Africa

Thomas KA, Okoro C, Ntshiqa T, Damovsky V, Goldberg D, Ramokhoase O, et al.

PLOS Glob Public Health. 2026 Jan 30;6(1):e0005047.

View publication

Geospatial inequalities in zero-dose vaccination and structural determinants: Insights from sub-Saharan Africa (2015-2023)

Wand H, Naidoo S, Moodley J, Govender V

Vaccine. 2026 Jan 25;71:128062.

View publication

Barriers and facilitators of implementing public-private mix approaches for active tuberculosis case finding and health insurance access in at-risk populations in Ghana: a qualitative study

Hayibor KM, Kenu E, Bandoh DA, Owusu-Arthur B, Odikro MA, Mensah GI, et al.

Front Health Serv. 2026 Jan 12;5:1738753.

View publication

The effects of war on digital adherence technology engagement for TB treatment in Ukraine

Deyanova N, McQuaid CF, Kochanov V, Bogdanov A, Madden N, Charalambous S, et al.

IJTLD Open. 2026 Jan 9;3(1):24-30.

View publication

A Mixed-Method Evaluation of the Association Between Attitudes Toward Gender-Based Violence and Sexual Behaviors Among Adolescents and Young Adults in Rustenburg, South Africa

Makkan H, Mlotshwa M, Masibi P, Molefe T, Mthembu F, Maenetje P, et al.

AIDS Behav. 2026 Jan 9.

View publication

Baseline determinants of adherence for drug-sensitive TB treatment in a South African prospective cohort: a focus on HIV infection and anti-retroviral therapy, clinical care access, and TB stigma

Steulet A, Hippner P, Maraba N, Jennings L, Rabothata I, Mukora R, et al.

BMC Infect Dis. 2026 Jan 7.

View publication

World Health Organization-Recommended Periodic Presumptive Treatment Versus Doxycycline Post-Exposure Prophylaxis for Sexually Transmitted Infection Control Among Men Who Have Sex With Men in Kenya: Protocol for a Randomized Controlled Trial

Graham SM, Otieno FO, Kimani J, Barrientos A, Soge OO, Sharma M, et al.

JMIR Res Protoc. 2026 Jan 6;15:e81113.

View publication

HIV prevention must incorporate acute HIV infection screening

Hamers RL, Januraga PP, Sanders EJ

Lancet HIV. 2026 Jun;13(6):e363.

View publication

A Four-Item Risk Score to Target Acute HIV Infection Testing Among Men Who Have Sex With Men in Indonesia: Development and Validation in the INTERACT Prospective Cohort

Lazarus G, Kawi NH, Luis H, Rahmawati DP, Sihotang EP, Oktaviani M, et al.

J Int AIDS Soc. 2026 Apr;29(4):e70111.

View publication

Building Trust and Engaging Communities for HIV Prevention Research Globally

Andrasik M, Broder G, Louis K, Baepanye K, Kamel L, Davis A, et al.

AIDS Educ Prev. 2026 Feb;38(1):1-17.

View publication

Qualitative Identification of HIV Care Engagement Challenges and Preferences for Differentiated Care Service Delivery Models Post-Incarceration in South Africa

Mqedlana-Ntombela N, Mabuto T, Owczarzak J, Charalambous S, Hoffmann CJ

Inquiry. 2026 Jan-Dec;63:469580261421077.

View publication

Randomised Trial of a Single Dose of Ad26.COV2.S, BNT162b2 or SARS-CoV-2-rS-PN in Previously Vaccinated and Unvaccinated Adults Living with and without HIV in South Africa: Safety and Immunogenicity

Govender V, Reddy T, Maenetje P, Beattie T, Adonis T, Nielson T, et al.

The Lancet HIV, 2026; 13, e163-e175.

View publication
2025 112 publications

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV

Mkhize NN, Zhang B, Brackett C, Elyanu PJ, Tapley A, Dadabhai S, et al.

Nat Commun. 2025 Oct 6;16(1):8876.

View publication

Rates and Risk Factors for On-Treatment Mortality Among a Cohort of Adults Treated for Drug-Sensitive Tuberculosis: Analysis of Data From the Adherence Support Coalition to End Tuberculosis Consortium in Five Countries

Tadesse AW, Maraba N, Alacapa J, Gamazina K, Dube T, Onjare B, et al.

Trop Med Int Health. 2025 Oct 3. Epub ahead of print.

View publication

Shewamene Z, Goscé L, van Rest J, Madden N, Charalambous S, van Kalmthout K, Bedru A, Letta T, Jerene D, Fielding KL

Tadesse AW, Sahile M, Foster N, McQuaid CF, ....

Digital adherence technology interventions to reduce poor end-of-treatment outcomes and recurrence among adults with drug-sensitive tuberculosis in Ethiopia: a three-arm, pragmatic, cluster-randomised, controlled trial. Lancet Digit Health. 2025 Sep 29:100895.

View publication

Acceptability of Digital Adherence Technologies to support people with drug-susceptible TB in South Africa

Dube TN, Mboniswa F, de Groot L, Khumalo S, Maraba N, Ndlovu N, et al.

PLoS One. 2025 Sep 24;20(9):e0332103.

View publication

Uptake of a Case Management Intervention for Continuity of Human Immunodeficiency Virus Treatment Among Individuals Released From Incarceration Living With HIV in South Africa

Ndini P, Mabuto T, Charalambous S, Chimoyi L, Wahome E, Hoffmann CJ, Ndlovu N

J Correct Health Care. 2025 Sep 24.

View publication

Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial

Kendall MA, Hughes MD, Kim S, Aaron LA, Naini L, Suryavanshi N, et al.

Contemp Clin Trials. 2025 Sep 22;158:108084.

View publication

"If we lose it, we are worried": Individual and provider level perceptions towards weight change among people living with HIV who undergo TB screening in routine health care settings in Gauteng Province, South Africa

Dube TN, Mboniswa F, Qwana SE, Charalambous S, Ndlovu N, Grant AD, et al.

PLoS One. 2025 Sep 22;20(9):e0331904.

View publication

Evaluation of QIAreach QuantiFERON-TB lateral-flow nanoparticle fluorescence assay for TB infection diagnosis among TB household contacts in three high-burden settings

Ntshiqa T, Fasanmi A, Nagudi J, Tsope L, Copas A, Stender S, et al.

PLoS One. 2025 Sep 19;20(9):e0332125.

View publication

No evidence of MMR induced trained immunity to prevent SARS COV2: results from a multi-centre RCT

Delany-Moretlwe S, Dehbi HM, Sikazwe I, Kyei G, Koram K, Dubberke E, et al.

Front Immunol. 2025 Sep 16;16:1588190.

View publication

Targeted transcriptomic analyses of tuberculosis treatment response and outcomes in The Gambia

Manneh IL, Darboe F, Jobe H, Sarr Kuyateh B, Cham O, Owolabi O, et al.

Front Tuberc. 2025 Sep 2;3:1540194.

View publication

The treatment gap and the HIV care continuum for cisgender men who have sex with men in three South African cities: Findings from a biobehavioural survey, 2019

Giovenco D, Mabuto T, Manyuchi A, Savva H, McIntyre A, Puren A, et al.

PLOS Glob Public Health. 2025 Sep 2;5(9):e0004874.

View publication

Scaling up tuberculosis case finding via private providers in Ghana: an impact evaluation using interrupted time series

Hayibor KM, Kenu E, Mensah GI, Awalime D, Anaman J, Asante-Poku A, et al.

Front Public Health. 2025 Aug 26;13:1598269.

View publication

Investigating genetic, antigenic, and structural diversity in the Neisseria gonorrhoeae outer membrane protein, PorB: implications for vaccine design

Harrison OB, Bash M, Ramirez-Bencomo F, Thistlethwaite A, Jones R, Stejskal L, et al.

mBio.2025 Aug 25:e0130925.

View publication

Assessment of the Syndemic Relationship Between Individual, Social, and Structural Determinants of Tuberculosis Among People Living in Johannesburg, South Africa

Tanyanyiwa FT, Van Wyk RH, Setswe KG

Int J Environ Res Public Health. 2025 Aug 14;22(8):1272.

View publication

Preventing multidrug resistant tuberculosis: the dawn of a new era

Churchyard GJ, Swindells S, Gupta A, Shah NS, Hughes M, Kim S, et al.

Clin Inf Dis 2025 Aug 7:ciaf426.

View publication

DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis

Tukvadze N, Mashatole S, Jacobs A, Ngwanto T, Heinrich N, Van Rie A, et al.

BMC Infect Dis. 2025 May 28;25(1):768.

View publication

An evaluation of a choice architecture-based intervention on prescribing of TB preventive treatment to people living with HIV in southern Africa (the CAT study): a cluster-randomised trial

Shearer K, Nonyane BAS, Mulder C, Kaonga E, Nyirenda R, Mbendera K, et al.

BMJ Glob Health. 2025 May 24;10(5):e016921.

View publication

Golub JE, Chaisson RE, Churchyard G, Bedru A

Salazar-Austin N, Cohn S, Nonyane BAS, Mulder C, Mulatu F, Bayu S, ……………

Effectiveness of a Home-based Approach to Child Contact Investigation and TPT Management by Community Health Workers in Ethiopia: A Pragmatic Cluster-randomized Trial. Clin Infect Dis. 2025 May 16: ciaf203.

View publication

Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans

Willis JR, Prabhakaran M, Muthui M, Naidoo A, Sincomb T, Wu W, et al.

Science. 2025 May 15:eadr8382. Epub ahead of print.

View publication

Is global health security worth 0.01% of our gross domestic product? PLOS Glob Pub Health

Ooms G, Assefa Y, Charalambous S, Dah TTE, Decoster K, de Jong B, et al.

2025 May 14;5(5):e0004491.

View publication

Neuromyelitis optica causing vision loss during TB treatment with sutezolid: evidence of aberrant immunity following infection

Glover NA, Paramo L, Giangregorio S, Sukwana B, Koele SE, Charalambous S, et al.

IJTLD Open. 2025 May 12;2(5):306-309.

View publication

Resistance to tuberculin skin test/interferon-gamma release assay conversion among highly TB exposed, HIV infected goldminers in South Africa

Ntshiqa T, Velen K, Ginindza S, Nhlangulela L, Charalambous S, Hawn TR, et al.

PLoS One. 2025 May 9;20(5):e0318819.

View publication

Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial

Weld ED, Beattie T, Moodley J, Mapendere M, Salles I, Solans BP, et al.

Lancet HIV. 2025 May 8:S2352-3018(25)00002-5.

View publication

Cost and cost-effectiveness of pediatric home-based versus facility-based TB Preventive Treatment in Ethiopia (CHIP-TB)

Malhotra A, Bedru A, Mulatu F, Nonyane BAS, Cohn S, Mulder C, et al.

PLOS Glob Pub Health. 2025 Apr 30;5(4):e0004466.

View publication

Finding the balance between rigour and relevance: implementing adaptations to the implementation of a pragmatic randomised controlled trial of a two-way texting intervention for voluntary medical male circumcision in South Africa

Setswe G, Day S, Ndebele F, Pienaar J, Ncube V, Feldacker C

BMJ Open. 2025 Apr 28;15(4): e091934.

View publication

Pilot of Methadone for Recently Incarcerated People with Human Immunodeficiency Virus and Opioid Use in South Africa

Bhoora U, An Y, Owczarzak J, Ndini P, Moyo D, Shelly S, et al.

J Correct Health Care. 2025 Apr 23.

View publication

Improving Health and Well-Being of People with Post-COVID-19 Consequences in South Africa: Situation Analysis and Pilot Intervention Design

Glover NA, Sathar F, Mokome P, Mathabela N, Taleni S, van Blydenstein SA, et al.

JMIR Form Res. 2025 Apr 10;9:e58436.

View publication

Predictors of unsuppressed viral load among men who have sex with men living with HIV in South Africa

van der Mannen JS, Furamera S, Pienaar J, Komane P, Shokota L, Ramashala B, et al.

AIDS. 2025 Apr 9. Epub ahead of print.

View publication

Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial

Hemmerling A, Mitchell CM, Demby S, Gebremichael M, Elsherbini J, Xu J, et al.

Lancet Microbe. 2025 Apr 3:101037. Epub ahead of print.

View publication

Zwane Z, Cox S, Deaton C, Ebrahimi R, Wong P, Singh R, Brown LB, Carter CC, Das M, Baeten JM, Ogbuagu O; PURPOSE 2 Study Team

Kelley CF, Acevedo-Quiñones M, Agwu AL, Avihingsanon A, Benson P, Blumenthal J, …………

Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons. N Engl J Med. 2025 Apr 3;392(13):1261-1276. (Purpose 2 Study Team – I Shibambo, K Mngadi).

View publication

Deciphering HIV vaccine-induced Antibody response according to ethnicity

Lin LY, Ferte T, Chachage M, Casteano C, Laumond G, Schmidt S, et al.

AIDS. 2025 Mar 31.

View publication

Acceptability of the live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) among young women at high risk of HIV acquisition in South Africa: data from the phase 2 placebo-controlled trial

Hemmerling A, Govender V, Dong K, Dong M, Pillay S, Ndung'u T, et al.

Front Reprod Health. 2025 Mar 25;7:1544458.

View publication

Quantifying Hypertension and Cardiovascular Conditions in South Africa

Wand H, Naidoo S, Govender V, Moodley J

J Prev (2022). 2025 Mar 24.

View publication

Unveiling a hidden phenotype of early tuberculosis

Ehrlich J, Suñer C, Churchyard G, Cobelens F, Hatherill M, Mendelsohn SC, et al.

Lancet Respir Med. 2025 Mar 21:S2213-2600(25)00092-X.

View publication

Impact of COVID-19 on the HIV Treatment Outcomes Among Men Who Have Sex with Men in South Africa After the Implementation of a Differentiated Service Delivery Model: An Interrupted Time Series Analysis

Sebati B, Phalane E, Shiferaw YA, Pienaar J, Furamera S, Phaswana-Mafuya RN

Int J Environ Res Public Health. 2025 Mar 19;22(3):452.

View publication

Costs and cost-effectiveness of integrated screening for non-communicable diseases in TB contacts

Hamada Y, Mukora R, Pelusa R, Ntshiqa T, Shedrawy J, Velen K, et al.

IJTLD Open. 2025 Mar 12;2(3):160-165.

View publication

Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trials

Jerene D, van Kalmthout K, Levy J, Alacapa J, Deyanova N, Dube T, et al.

Lancet. 2025 Mar 11.

View publication

Evaluating community knowledge of tuberculosis preventive therapy in rural South Africa

Foppiano Palacios C, Moll AP, Shrestha R, Kompala T, Davis JL, Charalambous S, et al.

BMC Public Health. 2025 Mar 7;25(1):918.

View publication

POR TB study group

Borges ÁH, Russell M, Tait D, Scriba TJ, Nemes E, Skallerup P, et al.

Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial. Lancet Infect Dis. 2025 Mar 5:S1473-3099(24)00814-4.

View publication

Understanding the occurrence and determinants of catastrophic costs of rifampicin resistant tuberculosis in South Africa to inform a patient-centered care program

Wang Z, Ndebele F, Sibeko ZR, Bohlela S, Segwaba P, Fanampe B, et al.

Int Journal of Infect Dis. 2025 Mar 1;152:107756.

View publication

Choice-architecture TB preventive therapy prescribing for HIV patients in Mozambique

Salles I, Munguambe S, Chiau R, Valverde E, Golub JE, Hoffmann CJ, Shearer K

Public Health Action. 2025 Mar 1;15(1):21-25.

View publication

Risk factors for PrEP and ART medication adherence challenges in cis-gender South African men who have sex with men in Johannesburg and Pretoria

Pienaar J, Tsope L, Mabena M, Komane P, Sibanyoni M, Ramashala B, et al.

Int Health. 2025 Feb 13:ihae090.

View publication

The potential impact of new tuberculosis vaccines on the burden of tuberculosis in people with HIV in South Africa

Sumner T, Clark RA, Prys-Jones TO, Bakker R, Churchyard G, White RG

AIDS. 2025 Feb 1;39(2):175-183.

View publication

BMI as a predictor of progression from TB infection to active TB in PLHIV

Nguenha D, Ndebele F, Saavedra B, Mambuque E, Acácio S, Cárdenas V, et al.

Int J Tuberc Lung Dis. 2025 Feb 1;29(2):54-59.

View publication

CoVPN 3008 Ubuntu Study Team

Garrett N, Tapley A, Hudson A, Dadabhai S, Zhang B, Mgodi NM, et al.

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study. EClinicalMedicine. 2025 Jan 20; 80:103054.

View publication

N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis

Mapamba DA, Sabi I, Lalashowi J, Sauli E, Buza J, Olomi W, et al.

J Infect. 2025 Jan 3;90(2):106379.

View publication

Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'

Kenny A, van Duijn J, Dintwe O, Heptinstall J, Burnham R, ……………….., et al.

EBioMedicine 2024;108: 105320. EBioMedicine. 2025 Sep;119:105874.

View publication

A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials

Moodie Z, Li SS, Giorgi EE, Williams LD, Dintwe O, Carpp LN, et al.

Emerg Microbes Infect. 2025 Apr;14(1):2485317.

View publication

Inflammatory profiles in sputum and blood of people with TB with and without HIV coinfection

Auld SC, Queiroz ATL, Araujo-Pereira M, Maenetje P, Mofokeng N, Mngomezulu L, et al.

Tuberculosis (Edinb). 2025 Mar;151:102612.

View publication

Preferences for HIV pre-exposure prophylaxis formulations and delivery among young African women: results of a discrete choice experiment

Dlamini WW, Mirembe BG, Krows ML, Peacock S, Kotze PL, Selepe P, et al; INSIGHT Study Team

J Int AIDS Soc. 2025 Feb;28(2):e26422.

View publication

Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043-02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial

Heinrich N, de Jager V, Dreisbach J, Gross-Demel P, Schultz S, Gerbach S, et al.

Lancet Microbe. 2025 Feb;6(2):100952.

View publication

Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data

Pelzer PT, Stuck L, Martinez L, Richards AS, Acuña-Villaorduña C, Aronson NE, et al.

Lancet Microbe. 2025 Feb;6(2):100961.

View publication

Review of Impact of Risk Reduction Sessions on Sexual Behaviors in HIV Prevention Trials: Insights from Africa

Wand H, Reddy T, Moodley J, Naidoo S, Ramjee G

Arch Sex Behav. 2025 Feb;54(2):805-815.

View publication

Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review

Chihota V, Gombe M, Gupta A, Salazar-Austin N, Ryckman T, Hoffmann CJ, et al.

Drugs. 2025 Feb;85(2):127-147.

View publication

Frequency of tuberculosis symptoms at repeat visits amongst adults attending for HIV care in Gauteng province, South Africa

Ntshiqa T, Jawad S, Hanifa Y, Chihota V, Charalambous S, Ndlovu N, et al.

BMC public health 2025; 25: 3667.

View publication

Climate change and tuberculosis: an analytical framework

Saunders MJ, Boccia D, Khan PY, Goscé L, Gasparrini A, Clark RA, et al.

The Lancet Respiratory medicine 2025.

View publication

Shesha, a WhatsApp Chatbot for Linking Household Contacts to Tuberculosis Treatment or Preventive Therapy in South Africa: Design and Development

Mudzengi DL, Ntshiqa T, Hamada Y, Ndebele F, Mpanza T, Kyobutungi B, et al.

JMIR formative research 2025; 9: e71793.

View publication

Integrating PrEP and Sexual Reproductive Health Services for Adolescent Girls and Young Women in South Africa: A Scoping Review

Moodley R, Giovenco D, Williams M, Aguilar FA, Ngo CP, Souabni O, et al.

AIDS and behavior 2025.

View publication

Acceptability and feasibility of a group intervention for long COVID in Johannesburg, South Africa: a mixed-method study

Ramachandran R, Sathar F, Mokome P, Mathabela N, Mahlase E, Charalambous S, et al.

Front Health Serv 2025; 5: 1666387.

View publication

Optimising child-friendly TB preventive treatment regimens

Mulder C, Bergman AJ, Mulatu F, Chaisson R, Churchyard G, Bedru A, et al.

IJTLD Open 2025; 2: 671-676.

View publication

Feasibility and acceptability of self-testing for COVID-19 in Ethiopia: a mixed-methods study

Mitiku I, Keller S, Abera A, Hailu H, Demissie Y, Melese D, et al.

IJTLD Open 2025; 2: 630-638.

View publication

Assessing Vaccine Confidence Using the Vaccine Hesitancy Scale Among Adolescent Girls and Young Women at Risk of HIV Acquisition Living in Uganda, Zambia, and South Africa

Kyakuwa N, Ssetaala A, Price MA, Nanvubya A, Abyesiza JM, Basalirwa G, et al.

Vaccines (Basel) 2025; 13.

View publication

"They recognize me as a doctor": A peer mobilisation training programme to promote oral HIV self-testing and referral for acute HIV infection screening among gay and bisexual men and transgender women in coastal Kenya, an exploratory study

Palmer S, Dijkstra M, Kigoro A, Mohamed K, Mukuria N, Mahmoud S, et al.

PLoS One 2025; 20: e0322255.

View publication

Using participatory methods to develop a narrative intervention to alleviate distress in children hospitalised with TB in South Africa: The DIMPle project

October CD, Baloyi DP, Viljoen L, Raad R, Wademan DT, Palmer M, et al.

PLoS One 2025; 20: e0338394. [2.6] HSD; TB.

View publication

Evaluating the New TB Antigen-Based Skin Test to Diagnose TB Infection in South Africa

Sathar F, du Toit C, Chihota V, Eastop C, Ndjeka N, Motlhaoleng K, et al.

Tropical medicine and infectious disease 2025; 10(12):33. IF 2.81; IRD/HSD; TB.

View publication

Screening for asymptomatic tuberculosis among adults with household exposure to pulmonary tuberculosis: a prospective observational cohort study

Mendelsohn SC, Mulenga H, Tameris M, Moloantoa T, Malherbe ST, Katona A, et al.

Lancet Glob Health. 2025;13(11):e1869-e1879.

View publication

The effectiveness, cost-effectiveness, budget impact, and return on investment of scaling up tuberculosis screening and preventive treatment in Brazil, Georgia, Kenya, and South Africa: a modelling study

Vesga JF, Mohamed MS, Shandal M, Jabbour E, Lomtadze N, Kubjane M, et al.

Lancet Glob Health. 2025 (11):e1857-e1868.

View publication

The effect of smart pillboxes on TB stigma among adults in a cluster-randomised TB treatment trial

Jennings L, Maraba N, Mukora R, Hippner P, Velen K, Orrell C, et al.

IJTLD Open. 2025;2(10):583-589.

View publication

Peer-assisted HIV partner notification services to strengthen index partner testing for newly diagnosed men who have sex with men in coastal Kenya

Adrian H, Dijkstra M, Mahmoud S, Mohamed K, Gichuru E, Sanders EJ, et al.

PLoS One. 2025; 20(10):e0333707.

View publication

HIV index testing implementation at public health clinics in South Africa

Mshweshwe-Pakela N, Mabuto T, Lebyane R, Hamisi M, Gininza S, Chihota V, Hoffmann C

S Afr Med J [Internet]. 2025;115(8):e2652.

View publication

Treatment completion and challenges in rolling out 12-dose weekly rifapentine plus isoniazid to prevent tuberculosis among people living with HIV and pediatric household contacts in Brazil

Salles I, Garcia de Oliveira J, Brito de Souza A, Cohn S, Spener-Gomes R, Dourado de Andrade S, et al.

J Bras Pneumol.2025;51(4):e20250125.

View publication

Strengthening evidence for text-based telehealth in post-operative care: A pragmatic study of the reach and effectiveness of two-way, text-based follow-up after voluntary medical male circumcision in South Africa

Feldacker C, Fabens I, Dong TQ, Moyo K, Makhele C, Phohole M, et al.

PLoS One 20(10): e0314436.

View publication

Understanding patient experiences: A mixed-methods study on barriers and facilitators to TB care seeking in South Africa

Sathar F, Du Toit C, Charalambous S, Chihota V, Evans DH, Chetty-Makkan CM

Trop. Med. Infect. Dis. 2025, 10, 283.

View publication

Should Digital Interventions for HIV Self-Testing Be Regulated with World Health Organization Prequalification?

Fischer AE, Lalla-Edward ST, Edward V, Abrahams M, Shankland L, de Wit J

JMIR mHealth and uHealth 2025; 13: e60276.

View publication

Drought, Extreme Heat, and Intimate Partner Violence in Low- and Middle-Income Countries

Wang P, Chu L, Ban J, Asare EO, Sivakami M, Henao AR, et al.

JAMA Netw Open 2025; 8: e2527818.

View publication

The high cost of donor withdrawal: implications for tuberculosis progress

Ndjeka N, Boffa J

Lancet Glob Health 2025; 13: e1490-e1491.

View publication

Social and Structural Interventions to Reduce Strikingly High Post-Hospital Mortality for People Living with HIV in Sub-Saharan Africa

Claassen CW, Mabuto T, Shearer K, Park J, Willkens M, Bwalya C, et al.

Current HIV/AIDS reports 2025; 22: 42.

View publication

Community and Universal Testing for TB among close contacts of microbiologically confirmed pulmonary TB patients in two high TB burden countries: a protocol for a pragmatic cluster-randomised control trial

Moyo M, Ntshiqa T, Hamada Y, …Kubeka G, Tsope L, Mukora R, et al.

Trials 2025; 26: 285.

View publication

Epidemiological factors associated with immunological resistance in household contacts exposed to active tuberculosis in South Africa: A logistic regression analysis

Maenetje N, Oladimeji M, Mlotshwa M, Hoft D, Lindan C, Wallis R, et al.

PLoS One 2025; 20: e0329562.

View publication

Drought, Extreme Heat, and Intimate Partner Violence in Low- and Middle-Income Countries

Wang P, Chu L, Ban J, Asare EO, Sivakami M, Henao AR, et al.

JAMA Netw Open 2025; 8: e2527818.

View publication

Statins for polycystic ovary syndrome in varying resource settings: a phenome-wide association study and evidence synthesis

Zahn LA, Budine TD, Shirey-Rice JK, Joly MM, Wallis RS, Bernard GR, et al.

Front Pharmacol 2025; 16: 1562587.

View publication

Medical technologists' experiences handling medical specimens during the COVID-19 pandemic

Mafolo MC, Mutava E, Sunnasy A, du Plessis-Faurie AS

Health SA 2025; 30: 2929.

View publication

Adaptation of Inuka coaching problem-solving therapy to support mental health and HIV medication adherence among status-neutral men who have sex with men in South Africa

Tsope L, van der Elst EM, Pienaar J, Denousse C, Mabena M, Komane P, et al.

Int Health 2025.

View publication

One year on - the long-term impact of COVID-19 pandemic and government restrictions on the health-seeking behaviour, financial security and mental health of TB survivors

Jinga N, Hirasen K, Ivanova O, Rachow A, Charalambous S, Lönnroth K, et al.

BMC Public Health 2025; 25: 2660.

View publication

Engagement With Digital Adherence Technologies as Measures of Intervention Fidelity Among Adults With Drug-Susceptible Tuberculosis and Health Care Providers: Descriptive Analysis Using Data From Cluster-Randomized Trials in Five Countries

Alacapa J, Tadesse AW, Deyanova N, Dube T, Mganga A, Powers R, et al.

JMIR Public Health Surveill 2025; 11: e62881.

View publication

Chlamydia and gonorrhoea infections in young Kenyan HIV-negative cisgender men who have sex with men and transgender women: a multicentre cohort study

Sanders EJ, Wahome E, Otieno F, Kimani J, Bentzer A, Okall D, et al.

BMJ Open 2025; 15: e098916.

View publication

Is South Africa ready for point-of-care, non-sputum tests for TB diagnosis? An assessment of end-user perceptions on a novel urine test and tongue swab for TB testing

Mqedlana-Ntombela N, Fargnoli V, Charalambous S, Velen K, Shilton S, Chihota V

BMC Health Services Res 2025; 25: 1013.

View publication

Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines

Ackerley CG, Edupuganti S, Yu C, Roxby AC, Seaton KE, Bekker LG, et al.

Front Immunol 2025; 16: 1557009.

View publication

Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferon-gamma release assay-positive participants

Cobelens F, Pelzer PT, Churchyard GJ, Garcia-Basteiro A, Hatherill M, Hill PC, et al.

Vaccine 2025; 61: 127301.

View publication

Analytical treatment interruption among women with HIV in Southern Africa who received VRC01 or placebo in the Antibody Mediated Prevention Study: ATI stakeholder engagement, implementation and early clinical data

Karuna S, Laher F, Dadabhai S, Yu PC, Grove D, Orrell C, et al.

J Int AIDS Soc 2025; 28: e26495.

View publication

When evidence is not enough: A qualitative exploration of healthcare workers' perspectives on expansion of two-way texting (2wT) for post- circumcision follow-up in South Africa

Fabens I, Makhele C, Igaba N, Moyo K, Ndebele F, Pienaar J, et al.

PLOS Digit Health 2025; 4: e0000867.

View publication

Decision-makers' perspectives on the implementation of COVID-19 self-testing in Mozambique

Mavume-Mangunyane E, Issufo S, Ndima S, Valverde E, Peregrino RR, Tasca B, et al.

Public Health Action 2025; 15: 52-57.

View publication

Provider perspectives on empirical antibiotic treatment for tuberculosis-like symptoms in South Africa's private general practice sector: A qualitative study in two cities

Chikovore J, Boffa J, Moyo S, Mak A, Gavu Z, Salomon A, et al.

PLOS Glob Pub Health 2025; 5: e0004742.

View publication

Pregnancy and contraceptive use among participants of childbearing potential in the HVTN 705 HIV vaccine trial in Southern Africa

Mda P, Mngadi K, Zhang B, Burnham R, Juraska M, Hyrien O, et al.

Front Rep Health 2025; 7: 1565933.

View publication

Mental Health, Substance Use, and Tuberculosis Preventive Therapy in People With HIV: A Prospective Cohort Study

Johnson AE, Chimoyi L, Shenoi S, Brault MA, Forastiere L, Charalambous S, et al.

Open Forum Infect Dis 2025; 12: ofaf303.

View publication

Risk factors associated with TB infection among household contacts of microbiologically confirmed pulmonary TB patients in three high TB burden countries

Ntshiqa T, Nagudi J, Hamada Y, Copas A, Stender S, Sabi I, et al.

J Infect Dis 2025.

View publication

Gender-affirming care is life-saving care: a response to international funding cuts for trans people in South Africa

Pienaar J, Tsope L, Moodley R, Giovenco D, Sanders E, van der Elst E, Operario D

Lancet Glob Health 2025; 13: e1168-e1169.

View publication

The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research?

Andrews JR, Charalambous S, Churchyard G, Cobelens F, Fernández-Escobar C, Frick M, et al.

Lancet Infect Dis 2025.

View publication

TB elimination in Southern Africa: overview and critical reflection

Boffa J, Vambe D, Khosa C, José B, Ndjeka N, Nkomo T, et al.

IJTLD Open 2025; 2: 381-387.

View publication

Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial

Minja LT, van der Feltz I, Manyama C, Mpagama S, Mhimbira F, Noreña I, et al.

Lancet Infect Dis 2025.

View publication

Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial

Heinrich N, Manyama C, Koele SE, Mpagama S, Mhimbira F, Sebe M, et al.

Lancet Infect Dis 2025.

View publication

Collagen-targeted PET/CT Imaging of Tuberculosis Patients

Ordonez AA, Willy Vangu MD, Rajaratnam A, Mofokeng N, Gabuza L, Maenetje P, et al.

Eur Respir J 2025.

View publication

Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials

White RG, Churchyard GJ, Horton KC, Fiore-Gartland A, Behr MA, Clark RA, et al.

Lancet Resp Med 2025.

View publication

Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01(E-4) in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial

Dagnew AF, Han LL, Naidoo K, Fairlie L, Innes JC, Middelkoop K, et al.

Lancet HIV 2025.

View publication

Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB

Koele SE, Stoycheva K, Mtweve C, Manyama C, Mpagama S, Mhimbira F, et al.

J Antimicrob Chemo 2025.

View publication

The delivery of new tuberculosis vaccines to people living with HIV - when to vaccinate?

Sumner T, Clark RA, Prys-Jones TO, Bakker R, Churchyard G, White RG

BMC Infect Dis 2025; 25: 878.

View publication

The impact of US funding cuts and stop work orders on TB services and research in South Africa

Ndjeka N, Kubjane M, Abdullah F, Mohr-Holland E, Subrayen P, Loveday M, et al.

Int J Tuberc Lung Dis. 2025; 2(4)1-3.

View publication

Improving tuberculosis diagnosis in South Africa’s private sector: The results of a pilot private-public mix intervention in eThekwini health district

Boffa J, Mhlaba T, Chibi B, Naidoo M, Lutchminarain K, Khine SH, et al.

PLOS Glob Pub Health. 2025; 5(3): e0004233.

View publication

Process Evaluation of Pragmatic Cluster-Randomized Trials of Digital Adherence Technologies for Tuberculosis Treatment Support: A Mixed-Method Study in Five Countries

Madden, N.; Tadesse, A.W.; Leung, C.L.; Goncalves Tasca, B.; Alacapa, J.; Deyanova, et al.

Trop. Med. Infect. Dis. 2025, 10, 68.

View publication

“Time to Change”: To What Extent Could Non-Sputum Sampling Accelerate the Fight Against Tuberculosis—A Qualitative Study Among End-Users. Trop Med and Infect Dis

Fargnoli V, Hanh HTM, Hoang LN, Mahesh A, Mqedlana-Ntombela N, Xavier J, et al.

2025; 10(2):44.

View publication

Knowledge and reporting of adverse events following childhood immunization (AEFI) among health workers and caregivers at Mengo Hospital (2021), Kampala, Uganda: A mixed-methods study

Watyaba B, Chimoyi L, Knezevic I, Malande OO, Kalutte H, Bazira H, et al.

PLOS Glob Pub Health 2025; 5: e0004827.

View publication

Population-Level Impact of Risk Factors on Stunting Among Children Under Five in Sub-Saharan Africa (2015-2022)

Wand H, Moodley J, Naidoo S, Govender V

Acta Paediatr 2025.

View publication
2024 1 publication

Treatment adherence and clinical outcomes amongst in people with drug-susceptible tuberculosis using medication monitor and differentiated care approach compared with standard of care in South Africa: a cluster randomized trial

Charalambous S, Maraba N, Jennings L, Rabothata I, Cogill D, Mukora R, et al.

EClinicalMedicine. 2024 Jul 27;75:102745.

View publication

Annual Reports

Read our latest reports, results, and organisational highlights.